Alerta De Seguridad para GLUCOSE-6 PHOSPHATE DEHYDROGENASE (G-6-PDH)

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Trinity Biotech.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2016-12-23
  • Fecha de publicación del evento
    2016-12-23
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: trinity biotech glucose-6 phosphate dehydrogenase (g-6-pdh) medical device manufacturer, trinity biotech, has issued a medical device safety alert concerning its glucose-6 phosphate dehydrogenase (g-6-pdh). the details of the affected device are as follows:- assay product code: 345a lot number: f117009 (expiry date: 04-apr-18) date of manufacture: 04 apr 16 assay product code: 345b lot number: f229031 (expiry date: 18-jul-18) date of manufacture: 18 jul 16 the manufacturer has identified a potential for misdiagnosis with lots f117009 and f229031. a recent investigation has identified that these two lots display a level of accuracy variation outside the historical qc product release process control charts for normal range controls, despite falling within the qc acceptance specification. kits from these two lots must be destroyed. investigation testing has shown that there is objective evidence that the accuracy issue affects the normal patient range and not the deficient range with a potential health hazard of a false positive result (normal patient diagnosed as deficient) or an invalid test result occurring. affected users and end-users are asked to comply with the following actions with immediate effect: discontinue the use of the lots f117009 and f229031. destroy any remaining product. in line with their laboratory’s internal procedures, consider the need to review results previously generated using these lots. notify all end-users of this notification. according to the manufacturer, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 23 december 2016.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Trinity Biotech GLUCOSE-6 PHOSPHATE DEHYDROGENASE (G-6-PDH)
  • Manufacturer

Manufacturer